Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Johannes Gutenberg University Mainz
With
Roche Pharma AG
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Chronic hepatitis B, HBe antigen negative
treatment with a stable oral antiviral treatment (not containing telbivudine) and a fully suppressed viral load for at least 12 months (below limit of detection in conventional HBV-PCR assays, i.e. \<116 IU / ml).
18-70 ys
willingness and ability to give informed consent and to follow study procedures
willingness to use adequate contraception
You may not be if
contraindications against treatment with pegylated interferon, e.g. depression, uncontrolled epilepsy, autoimmune diseases, pregnancy, leukocytopenia or thrombocytopenia at screening, etc.